ABUS
Arbutus Biopharma Corp
4.50$
-2.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +81.9% | +12.9% | +107.9% | -21.3% | -4.7% | -19.0% | -55.0% | -67.4% | +311.5% | +70.5% | -0.9% | -49.9% | -34.8% | +283.8% | +36.3% | +64.8% | +502.6% | -61.3% | -14.0% | -3.9% | -53.7% | +29.9% | +49.2% | -4.4% | -26.1% | -8.8% | -28.2% | |
| – | +196.5% | +24.8% | +97.3% | -21.9% | +3.1% | -28.3% | -62.0% | -49.3% | +320.9% | +17.3% | -9.3% | -27.8% | -35.5% | +343.7% | +37.3% | +65.5% | +58.0% | -27.9% | -2.4% | -0.1% | -27.4% | +36.1% | +25.8% | -5.9% | -12.6% | -3.6% | -25.8% | |
| – | +1,267.5% | -81.2% | +1,151.5% | -20.0% | +73.4% | -29.7% | -58.1% | -53.6% | +334.3% | +2.0% | +8.2% | -47.0% | -27.1% | +422.8% | +46.1% | +5.1% | +131.0% | -86.0% | +132.1% | -32.0% | -13.9% | +64.3% | +109.1% | -71.8% | -14.6% | +38.2% | -50.4% | |
| – | +203.8% | +22.2% | +98.4% | -19.7% | +2.7% | -36.2% | -58.1% | -53.6% | +334.3% | +24.2% | -11.2% | -47.0% | -27.1% | +422.8% | +46.1% | +63.3% | +61.6% | -28.0% | -3.1% | -1.4% | -27.1% | +35.7% | +26.0% | -5.4% | -14.2% | -2.7% | -25.4% | |
| – | +150.5% | +50.6% | +149.1% | -73.9% | -25.0% | +361.2% | -85.6% | +132.6% | +204.0% | -54.3% | +51.4% | +194.6% | -68.2% | +190.6% | -90.5% | +668.1% | -45.3% | -78.3% | +33.3% | +257.8% | -15.9% | +9.0% | -31.5% | +50.4% | +31.4% | +35.6% | -27.5% | |
| – | +0.0% | +20,830,700.0% | -100.0% | +0.0% | -100.0% | – | -100.0% | -50.0% | +21,510,400.0% | -33.3% | -100.0% | – | -100.0% | -204,479,961.0% | – | -100.0% | – | -100.0% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | +14.1% | +34.3% | +9.3% | -16.3% | -72.3% | -47.3% | +206.0% | +40.2% | +24.6% | +16.8% | -31.0% | -37.1% | +1.3% | +28.2% | +80.9% | +118.2% | +75.4% | -16.7% | -14.5% | -20.2% | -13.6% | -15.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -85.0% | +0.0% | -7.9% | -100.0% | – | – | – | – | – | – | |
| – | +150.5% | +50.6% | +149.1% | -73.9% | -25.0% | +361.2% | -85.6% | -100.0% | – | – | +12.5% | -100.0% | – | – | – | – | – | -71.8% | -41.0% | -25.2% | – | – | – | – | – | – | – | |
| – | +36.7% | +29.9% | +145.2% | +28.6% | -6.6% | +602.2% | -28.3% | -84.1% | +9.9% | -37.3% | +60.6% | +58.0% | -17.4% | +37.4% | +7.2% | +141.2% | +445.1% | -55.7% | -25.0% | -49.4% | +18.5% | +7.1% | -0.2% | +67.1% | -34.5% | -10.5% | -47.5% | |
| – | +59.4% | +43.9% | +35.6% | +85.8% | -5.5% | +140.1% | -79.7% | +163.2% | +11.2% | -37.3% | +60.6% | +24.9% | -15.9% | +60.1% | +14.3% | +15.0% | -26.5% | +0.2% | +12.3% | -5.6% | -30.3% | +21.9% | +17.6% | +192.8% | -31.6% | -30.5% | -61.5% | |
| – | – | +59.0% | +116.1% | +14.7% | +207.9% | +86.3% | -93.6% | +67.6% | +84.0% | +1,819.3% | -100.0% | – | – | – | -17.6% | -40.0% | +320.9% | +7.3% | -10.5% | – | – | +14.7% | -1.8% | -2.9% | +14.2% | +13.6% | +13.3% | |
| – | – | – | +33.7% | +75.8% | -14.0% | -75.0% | +38.3% | -75.6% | -0.3% | +62.4% | +292.0% | +52.5% | -58.7% | -36.0% | +51.0% | +68.0% | +27.7% | +23.2% | -38.2% | +60.6% | -24.9% | +24.9% | +6.0% | +10.9% | -8.4% | -28.1% | -49.4% | |
| – | – | – | +219.1% | -29.3% | +380.4% | +3,891.4% | +7.3% | -99.8% | -100.0% | – | – | – | – | – | – | – | – | – | +0.0% | – | – | – | – | – | – | – | – | |
| – | +86.3% | +11.7% | +104.8% | -26.2% | -4.3% | -124.2% | – | – | +11,711.6% | +108.4% | -7.4% | -69.7% | -51.5% | +686.1% | +44.6% | +48.7% | +522.4% | -62.9% | -10.1% | +9.7% | -63.7% | +40.2% | +66.2% | -19.2% | -22.5% | -8.2% | -21.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +30.2% | +74.9% | +2.9% | +29.5% | +8.5% | +8.1% | +0.1% | -50.0% | +23.6% | +70.2% | +27.2% | +0.1% | +9.5% | +26.5% | +6.9% | +46.6% | +102.6% | +16.7% | +3.1% | +1.1% | +3.2% | +32.8% | +40.1% | +42.1% | +10.0% | +11.8% | +3.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.